St. Jude Children's Research Hospital

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1962-01-01

Employees: -

Market Cap: -

Website: http://www.stjude.org/

Clinical Trials

Tumor Rebiopsy in Children and Adolescents With Recurrent or Progressive Solid Malignancies

Completed

Conditions: Tumor, Solid

Interventions: Procedure: Re-biopsy
Other: Questionnaire

First Posted Date: 2017-09-08

Last Posted Date: 2023-06-06

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 8

Registration Number: NCT03276702

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Validation Study of Pediatric Patient-Reported Outcomes

Active, not recruiting

Conditions: Tumor
Malignancy

First Posted Date: 2017-07-26

Last Posted Date: 2024-08-28

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 375

Registration Number: NCT03229837

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Next Generation Pathogen Sequencing for Prediction of Adverse Events

Active, not recruiting

Conditions: Bloodstream Infection

First Posted Date: 2017-07-21

Last Posted Date: 2024-10-08

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 160

Registration Number: NCT03226158

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Evaluation of Proton Therapy in Pediatric Cancer Patients

Recruiting

Conditions: Tumor

First Posted Date: 2017-07-21

Last Posted Date: 2024-02-07

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 1000

Registration Number: NCT03223766

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Development of the Pediatric Neurocognitive Functioning Questionnaire

Completed

Conditions: Neurocognitive Disorders

First Posted Date: 2017-07-11

Last Posted Date: 2018-03-27

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 42

Registration Number: NCT03213431

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Study of Venetoclax in Combination With Chemotherapy in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Leukemia of Ambiguous Lineage

Phase 1

Completed

Conditions: Acute Myeloid Leukemia

Interventions: Drug: Venetoclax
Drug: Cytarabine
Drug: Idarubicin
Drug: Intrathecal Triple Therapy
Drug: Azacitidine

First Posted Date: 2017-06-21

Last Posted Date: 2023-02-14

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 62

Registration Number: NCT03194932

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
🇺🇸
Lucille Packard Children's Hospital Stanford University, Palo Alto, California, United States
🇺🇸
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors

Phase 2

Completed

Conditions: Glioma of Brain
Craniopharyngioma
Ependymoma
Germ Cell Tumor

Interventions: Drug: Memantine
Other: Placebo
Other: Cognitive Assessment

First Posted Date: 2017-06-21

Last Posted Date: 2023-07-13

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 34

Registration Number: NCT03194906

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Cognitive Intervention at the End of Therapy for Survivors of Childhood ALL Treated on TOTXVI

Not Applicable

Completed

Conditions: Acute Lymphoblastic Leukemia

Interventions: Behavioral: Cognitive training

First Posted Date: 2017-06-15

Last Posted Date: 2022-03-28

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 50

Registration Number: NCT03187977

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia

Phase 2

Active, not recruiting

Conditions: Acute Myeloid Leukemia
Myelodysplastic Syndromes

Interventions: Drug: Azacitidine
Drug: Decitabine
Drug: Cytarabine
Drug: Daunorubicin
Drug: Etoposide
Combination Product: ITMHA
Drug: Idarubicin
Drug: Fludarabine
Drug: Mitoxantrone
Drug: Sorafenib
Drug: Erwinia asparaginase
Drug: G-CSF
Drug: Dexrazoxane
Drug: Asparaginase Erwinia Chrysanthemi, Recombinant-Rywn
Biological: Stem Cell Transplant

First Posted Date: 2017-05-23

Last Posted Date: 2024-05-29

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 206

Registration Number: NCT03164057

Locations: 🇺🇸
Rady Children's Hospital and Health Center, San Diego, California, United States
🇺🇸
Children's Hospital of Central California, Madera, California, United States
🇺🇸
Children's Hospital of Orange County, Orange, California, United States

and more 7 locations

Feasibility of Isolating P16 Expression

Completed

Conditions: Childhood Cancer

First Posted Date: 2017-05-19

Last Posted Date: 2019-05-06

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 85

Registration Number: NCT03160768

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy